相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。First data for sotorasib in patients with pancreatic cancer with KRAS p.G12C mutation: A phase I/II study evaluating efficacy and safety
John H Strickler et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Relevance of gene mutations and methylation to the growth of pancreatic intraductal papillary mucinous neoplasms based on pyrosequencing
Go Asano et al.
SCIENTIFIC REPORTS (2022)
ITIH5-Derived Polypeptides Covering the VIT Domain Suppress the Growth of Human Cancer Cells In Vitro
Michael Rose et al.
CANCERS (2022)
A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders
Francesca Tucci et al.
NATURE COMMUNICATIONS (2022)
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs
Sarah T. Diepstraten et al.
NATURE REVIEWS CANCER (2022)
The 8th Edition American Joint Committee on Cancer Staging for Hepato-pancreato-biliary Cancer
Xiaoyan Liao et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)
Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5
Eric D. Young et al.
BRITISH JOURNAL OF CANCER (2021)
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017
Daniel J. van Der Meer et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Chromothripsis drives the evolution of gene amplification in cancer
Ofer Shoshani et al.
NATURE (2021)
Recent trends in cancer therapy: A review on the current state of gene delivery
Esam Bashir Yahya et al.
LIFE SCIENCES (2021)
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma
Benjamin Emil Stubbe et al.
CANCERS (2021)
Discovery of Candidate DNA Methylation Cancer Driver Genes
Heng Pan et al.
CANCER DISCOVERY (2021)
The promise and peril of KRAS G12C inhibitors
Amanda R. Moore et al.
CANCER CELL (2021)
Internalization mechanisms of cell-penetrating peptides
Ivana Ruseska et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2020)
Bioinformatics and Biosimulations as Toolbox for Peptides and Peptidomimetics Design: Where Are We?
Ilda D'Annessa et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
LowARID1AExpression is Associated with Poor Prognosis in Hepatocellular Carcinoma
Sun Young Yim et al.
CELLS (2020)
Inter-α-Trypsin Inhibitor Heavy Chain 5 (ITIH5) Is a Natural Stabilizer of Hyaluronan That Modulates Biological Processes in the Skin
Sebastian Huth et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2020)
ARID1A Hypermethylation Disrupts Transcriptional Homeostasis to Promote Squamous Cell Carcinoma Progression
Qingyu Luo et al.
CANCER RESEARCH (2020)
Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis
Tadeusz Majewski et al.
CELL REPORTS (2019)
Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
Alex Friedlaender et al.
FRONTIERS IN ONCOLOGY (2019)
Smart cancer nanomedicine
Roy van der Meel et al.
NATURE NANOTECHNOLOGY (2019)
ITIH5 induces a shift in TGF-beta superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death
Michael Rose et al.
MOLECULAR CARCINOGENESIS (2018)
The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
Wei-Wei Zhang et al.
HUMAN GENE THERAPY (2018)
Defining Driver DNA Methylation Changes in Human Cancer
Gerd P. Pfeifer
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
ARID1A loss in cancer: Towards a mechanistic understanding
Radhika Mathur
PHARMACOLOGY & THERAPEUTICS (2018)
ITIH5 mediates epigenetic reprogramming of breast cancer cells
Michael Rose et al.
MOLECULAR CANCER (2017)
Synthetic Peptides as Protein Mimics
Andrea Gross et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2016)
MethylMix: an R package for identifying DNA methylation-driven genes
Olivier Gevaert
BIOINFORMATICS (2015)
Phase I/II Study of Azacitidine, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy
Rakesh Singal et al.
CLINICAL GENITOURINARY CANCER (2015)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
The Phyre2 web portal for protein modeling, prediction and analysis
Lawrence A. Kelley et al.
NATURE PROTOCOLS (2015)
Gefitinib and Erlotinib in Metastatic Non-Small Cell Lung Cancer: A Meta-Analysis of Toxicity and Efficacy of Randomized Clinical Trials
Mauricio Burotto et al.
ONCOLOGIST (2015)
Epigenetic therapy for solid tumors: from bench science to clinical trials
Yen-Yi Juo et al.
EPIGENOMICS (2015)
Next-generation sequencing to guide cancer therapy
Jeffrey Gagan et al.
GENOME MEDICINE (2015)
Epigenetic treatment of solid tumours: a review of clinical trials
Clara Nervi et al.
CLINICAL EPIGENETICS (2015)
Is cancer gene therapy an empty suit?
Malcolm K. Brenner et al.
LANCET ONCOLOGY (2013)
Risk of Morbidity and Mortality Following Hepato-Pancreato-Biliary Surgery
Peter J. Kneuertz et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues
Gilad Landan et al.
NATURE GENETICS (2012)
Stability of peptides and therapeutic success in cancer
Marlene Pernot et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
Nikhil Wagle et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib
Vince D. Cataldo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization
Luca Gentilucci et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Cai-Hong Yun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation
J. Veeck et al.
ONCOGENE (2008)
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma
E. Dahl et al.
ONCOGENE (2007)
DNA methylation analysis by pyrosequencing
Joeg Tost et al.
NATURE PROTOCOLS (2007)
Mechanisms of Disease: oncogene addiction - a rationale for molecular targeting in cancer therapy
I. Bernard Weinstein et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin α2 as a potential novel prognostic marker in breast cancer
Edgar Dahl et al.
CLINICAL CANCER RESEARCH (2006)
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis
J. Veeck et al.
ONCOGENE (2006)
Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer
E Dahl et al.
JOURNAL OF PATHOLOGY (2005)
ITIH5, a novel member of the inter-α-trypsin inhibitor heavy chain family is downregulated in breast cancer
M Himmelfarb et al.
CANCER LETTERS (2004)
The Wnt antagonist sFRP1 in colorectal tumorigenesis
GM Caldwell et al.
CANCER RESEARCH (2004)
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
KH Emami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Searching for Cancer Information on the Internet: Analyzing Natural Language Search Queries
Judith L. Bader et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2003)
分享论文
